TOV promotes the development and commercialization of technologies and innovations created across all of NYU's campuses.
Manhattan, NY
Joined March 2019
- Tweets508
- Following552
- Followers396
- Likes675
📢 NYU - Still time to register for our upcoming 4-part webinar series: Intellectual Property for NYU Innovators to learn how innovations are protected at NYU.
Oct 9th, Oct 16th, Oct 25th, Oct 30th, 9:30 - 10:30 AM ET.
Register here:
troutman.zoom.us/webinar/reg…
@troutmanpepper
📢 TOV has an exciting opportunity to join the team as a Financial Analyst.
The role will provide general financial analysis & reporting to support TOV's overall financial results, drive operational improvements, & find innovative solutions to challenges.
jobs.nyulangone.org/job/2091…
📢 NYU - Register for our 4-part webinar series: Intellectual Property for NYU Innovators to learn how innovations are protected at NYU: troutman.zoom.us/webinar/reg…
Presenters include Drs. Shilpa Patel, PhD, JD, and @ChitaleSadhana from TOV along with attorneys from @troutmanpepper.
Technology Opportunities & Ventures (TOV) is excited to publish the Innovators’ “Bill of Rights” as part of our continuing effort to provide clarity into the commercialization process and improve the services we provide to NYU Innovators.
Learn more ➡️ tov.med.nyu.edu/news/introdu…
The NYU Innovator "Bill of Rights" is an outline of what can be expected from the TOV team during IP protection and commercialization and a communication timeline that we are committed to following.
Check out the NYU Innovator "Bill of Rights" ➡ tov.med.nyu.edu/for-innovato…
📢Still time to apply to participate in the Investor & Innovator Exchange on 6/10, hosted by TOV & @BioLabsNY.
The event will bring together founders, investors, & industry stakeholders to foster meaningful connections & explore investment opportunities.
biolabsnyu.info/2024ixi
The program includes a dynamic mix of pitch presentations, venture-focused expert panels, and targeted networking sessions.
#InvestorExchange #BiotechInvesting #NYLifescienceStartups #BioPharmaCollaborations #NYUInnovation #VentureCapital
🎉Join us in welcoming Sofia Bakogianni, PhD to the team as a Life Sciences Licensing Associate.
Sofia will help manage activities related to the disclosure and protection of new innovations & the transfer of life sciences technology from the University to the marketplace!
TOV is excited to announce that the NYU startup Imagenomix has launched to improve access to cancer testing.
Imagenomix is developing a SaaS cancer predictor that delivers fast & affordable diagnostic results through advanced AI capabilities.
Learn more -tov.med.nyu.edu/news/new-sta…
A study by @nyulangone & @UniofOxford researchers is featured on the @NIH Director's Blog. The study provides insights into the workings of an immune cell surface receptor (PD-1), and supports potential strategies for treating cancer & autoimmune disease.
directorsblog.nih.gov/2024/0…
📢 @nyuniversity researchers have identified a new synthetic pathway that turns plant biomass into valuable products & precursors for fragrances, flavors, pesticides, & more!
The lab has engineered a retro-synthetic strategy to depolymerize lignin & unleash its synthetic utility.
🤝NYU TOV is looking for a partner to help commercialize this promising new synthetic pathway! Learn more about the innovation and how you could partner with us ➡️license.tov.med.nyu.edu/prod… or contact BD Manager @DoctorDougB.
đź“– Read their research in greater detail:
pubs.acs.org/doi/10.1021/acs…
pubs.acs.org/doi/10.1021/acs…
#GreenResearch #NYUinnovation #Chemistry #GreenChemistry #Sustainability #Catalysis #CleanTech #AgriTech #AgTech #Fragrances #Flavors #Flavours
📢 NYU - Join us Thursday, 3/14 at noon for our Industry Insights on Research and Innovation Seminar, where we hear from startups turning cutting-edge science into impactful solutions.
March's guest speaker is Eric Ekland, PhD, co-founder, president, and CEO of Anvesana.
Join us 2/15 at noon for our next Industry Insights on Research & Innovation Seminar, where we hear from startups turning cutting-edge science into impactful solutions.
Our guest speaker is Dr. Joanne Kotz, co-founder & CEO of @jnanatx.
Register here:Â lnkd.in/eW53CpdD
📢TOV is hiring! join the team as a licensing associate for life sciences.
They will help manage activities related to the disclosure and protection of innovations and the transfer of life sciences-related tech from University to marketplace.
@AUTM
Apply➡️jobs.nyulangone.org/job/1982…
The Chen Lab at @nyuniversity has engineered an innovative #leukemic bone marrow-on-a-chip that replicates the B-cell acute lymphoblastic leukemia bone marrow microenvironment, allowing for accurate, rapid & inexpensive ex-vivo predictions of the efficacy of CAR T-cell therapies.
🤝NYU TOV is looking for a strategic partner to help commercialize this promising new research tool. Learn more about the innovation and how you could partner with us ➡license.tov.med.nyu.edu/prod…
📖Check out the recent publication with all the exciting data ➡pubmed.ncbi.nlm.nih.gov/3312…
Inverse named two NYU Langone Health medical advancements on its list of the most mind-blowing science breakthroughs of 2023!
inverse.com/science/most-min…
Join us 1/25 at noon for our Industry Insights on Research & Innovation Seminar - a series where we hear from startups turning cutting-edge science into impactful solutions.
Speakers: Dr. Shardule Shah, co-founder & CEO, and Dr. Prakrit Jena, co-founder and CTO, of @LimeBiotech.
